Barrington-Ham Awarded Hope Funds for Cancer Research Postdoctoral Fellowship
Chloe Barrington-Ham, PhD,, a postdoctoral associate in the lab of Alicia Darnell, PhD, has been awarded a three-year Hope Funds for Cancer Research Postdoctoral Fellowship, which provides an annual stipend and travel award to postdocs pursuing "highly innovative projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers."
New Funding Awards - October 2025 to December 2025
Congratulations to the following faculty members for receiving these sponsored research awards:
PCB ranked No. 8 in Pharmacology nationally
We are proud to share that the Department of Pharmacology and Cancer Biology has been ranked No.
Weber Barbier Awarded Jo Rae Wright Fellowship for Outstanding Women in Science
Margaret Weber Barbier, a graduate student in the lab of Trudy Oliver, PhD, received the Jo Rae Wright Fellowship for Outstanding Women in Science. Created in memory of Jo Rae Wright, former dean of the Duke University Graduate School and professor of cell biology, medicine, and pediatrics, this fellowship recognizes one Ph.D. student in the biomedical sciences "whose research shows particular creativity and promise."
Caminear Awarded Paul and Lauren Ghaffari Graduate Fellowship
Michael Caminear, a graduate student in the lab of Ann Marie Pendergast, PhD, has been awarded the Paul and Lauren Ghaffari Graduate Fellowship, which provides support to doctoral students pursuing oncology-related research.
Trudy Oliver Receives Lung Cancer Initiative Funding Award
Trudy Oliver, PhD, DCI member and professor of in the Duke Department of Pharmacology and Cancer Biology, received the Vicky Amidon Innovation in Lung Cancer Research Award from the Lung Cancer Initiative (LCI). The award recognizes and provides research funding for innovative lung cancer projects that will improve the lives of those diagnosed with lung cancer in North Carolina. Since 2008, LCI has funded more than $4.2 million in lung cancer research through programs like the research fellowship grant, health disparities in lung cancer grant in partnership with the V Foundation for Cancer Research, Career Development Award, and the Vicky Amidon Innovation in Lung Cancer Research Award.
Zou lab: A new weakness in cancer cells
One of the reasons cancer cells are so dangerous is their ability to shift between distinct “cell states,” a trick that helps them spread, survive treatment, and come back even after therapy initially works. Researchers from Duke University School of Medicine have discovered a new vulnerability that appears during the brief moments when cancer cells switch from one state to another. They also identified a way to exploit this weakness, opening a potential new path for cancer treatment.